WuXi partners with Pacific Biomarkers to gain access to more assays
WuXi PharmaTech is partnering with Pacific Biomarkers to gain access to its menu of validated biomarker assays to support WuXi's integrated clinical trial testing services.
Archives for March 12, 2014
US FDA slams Indian lab for lack of raw data
The US FDA has chastised India-based Canton Laboratories for failing to offer raw data on previously submitted statistics in April 2013.
Patheon and DSM complete $2.65bn merger to form private company 'DPx'
Patheon has merged with Royal DSM's pharmaceutical products business to form DPx in a $2.65bn (€1.9bn) deal that analysts believe has created the world's second biggest CMO.
Gov set on enhancing UK supply chain competitiveness
The UK Government has set out to make Britain a more attractive place from which to source drugs and ingredients by awarding a series of taxpayer funded grants to supply chain focused innovation projects.
Hydrocodone restrictions will put quotas on Vicodin production
Access to mixed hydrocodone painkillers such as AbbVie’s Vicodin will be restricted and production limited if plans by the US Drug Enforcement Administation (DEA) are cemented later this year.
AstraZeneca sells off UK site in Alderley Park, takes $275m hit
AstraZeneca is selling its Alderley Park site in Cheshire, UK, to Manchester Science Parks, a public-private partnership and science park operator.